Advertisement
Screener

VYOME HOLDINGS, INC. (HIND) Shareholders' Equity

2.8 / 5 stars · 68/120 Roast Me

VYOME HOLDINGS, INC. Shareholders' Equity

VYOME HOLDINGS, INC. (HIND) had Shareholders' Equity of $2.53 million as of 2025-09-30, per its 10-Q filed 2025-11-14.

Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent

us-gaap:StockholdersEquity · last filed 2025-11-14

  • 2025-09-30: Stockholders' Equity Attributable to Parent $2.53M.
  • 2025-06-30: Stockholders' Equity Attributable to Parent -$4.99M; Stockholders' Equity Attributable to Parent as first filed $5.83M.
  • 2025-03-31: Stockholders' Equity Attributable to Parent $1.23M.
  • 2024-12-31: Stockholders' Equity Attributable to Parent -$4.39M; Stockholders' Equity Attributable to Parent as first filed -$253.00K.
Period endStockholders' Equity Attributable to ParentStockholders' Equity Attributable to Parent as first filed
2025-09-30$2.53M
10-Q · filed 2025-11-14
2025-06-30-$4.99M
8-K · filed 2025-09-02
$5.83M
10-Q · filed 2025-08-14
2025-03-31$1.23M
10-Q · filed 2025-08-14
2024-12-31-$4.39M
10-Q · filed 2025-11-14
-$253.00K
10-K · filed 2025-04-04
2024-09-30$1.49M
10-Q · filed 2024-11-14
2024-06-30-$3.97M
8-K · filed 2025-09-02
$3.04M
10-Q · filed 2024-08-14
2024-03-31$4.53M
10-Q · filed 2025-08-14
2023-12-31-$6.17M
8-K · filed 2025-09-02
$6.66M
10-K · filed 2024-04-01
2023-09-30$3.08M
10-Q · filed 2024-11-14
2023-06-30$6.74M
10-Q · filed 2024-11-14
2023-03-31$7.76M
10-Q · filed 2024-08-14
2022-12-31$3.66M
10-K · filed 2025-04-04
2022-09-30$18.95M
10-Q · filed 2023-11-09
$20.94M
10-Q · filed 2022-11-14
2022-06-30$30.78M
10-Q · filed 2023-11-09
$32.36M
10-Q · filed 2022-08-19
2022-03-31$36.96M
10-Q · filed 2023-08-07
$38.63M
10-Q · filed 2022-05-23
2021-12-31$44.33M
10-K · filed 2024-04-01
$46.07M
10-K · filed 2022-04-08
2021-09-30$79.31M
10-K · filed 2023-04-17
$79.22M
10-Q · filed 2021-11-12
2021-06-30$58.13M
10-K · filed 2023-04-17
$58.12M
10-Q · filed 2021-08-16
2021-03-31$12.71M
10-K · filed 2023-04-17
$10.10M
10-Q · filed 2021-05-12
2020-12-31$14.49M
10-K · filed 2023-04-17
$4.67M
10-K · filed 2021-03-12
2020-09-30$17.08M
10-Q · filed 2021-11-12
$5.92M
10-Q · filed 2020-11-06
2020-06-30$19.15M
10-Q · filed 2021-11-12
$7.18M
10-Q · filed 2020-07-30
2020-03-31$21.57M
10-Q · filed 2021-08-16
$11.07M
10-Q · filed 2020-06-19
2019-12-31$24.11M
10-K · filed 2022-04-08
$15.85M
10-K · filed 2020-02-27
2019-09-30$20.07M
10-Q · filed 2019-11-08
2019-06-30$8.38M
10-Q · filed 2019-11-08
$8.39M
10-Q · filed 2019-07-24
2019-03-31$6.52M
10-Q · filed 2019-11-08
2018-12-31$13.11M
10-K · filed 2020-02-27
2018-09-30$20.15M
10-Q · filed 2019-11-08
2018-06-30$16.05M
10-Q · filed 2019-11-08
2018-03-31$24.42M
10-Q · filed 2019-11-08
2017-12-31$35.11M
10-Q · filed 2019-11-08
2017-09-30$43.52M
10-Q · filed 2017-11-03
2017-06-30$50.22M
10-Q · filed 2017-08-02
2017-03-31$57.07M
10-Q · filed 2017-05-10
2016-12-31$64.31M
10-K · filed 2018-03-05
2016-09-30-$67.09M
10-Q · filed 2016-11-10
2015-12-31-$55.14M
10-K · filed 2017-02-23

Similar stocks

Stock NameCountryMarket CapPE Ratio
Tvardi Therapeutics, Inc. (TVRD)United States$0.014B
BullFrog AI Holdings, Inc. (BFRG)United States$0.014B
ACTUATE THERAPEUTICS, INC. (ACTU)United States$0.015B
Anebulo Pharmaceuticals, Inc. (ANEB)United States$0.015B
LISATA THERAPEUTICS, INC. (LSTA)United States$0.014B-2.13
Lantern Pharma Inc. (LTRN)United States$0.015B-2.87
Vistagen Therapeutics, Inc. (VTGN)United States$0.013B-0.14
MUSTANG BIO, INC. (MBIO)United States$0.013B
Citius Pharmaceuticals, Inc. (CTXR)United States$0.016B-133.06
AEON Biopharma, Inc. (AEON)United States$0.013B-0.36